David Mrazek, M.D., Chair of Psychiatry and Psychology, recently received a $2.5 million grant from the National Institutes of Health to serve as the Program Director of the Mayo Clinic Center for Alcohol Addiction. The center will conduct pharmacogenomic and imaging studies designed to improve our understanding of the response of patients to pharmacological treatment of alcohol addiction.
“By using these additional funds to expand our DNA repository, our pilot study enrollment, and the interface between basic science and individualized treatment of addiction, we will be poised to successfully compete for funding for an additional five years,” says Dr. Mrazek.
The grant was a part of the American Recovery and Reinvestment Act and is intended to develop and implement critical research, stimulate future growth and to advance public health and health care delivery.
Dr. Mrazek became the Chair of the Board of the American Board of Psychiatry and Neurology in this month. The ABPN is a not-for-profit corporation dedicated to serving the public interest and the professions of psychiatry and neurology by promoting excellence in practice through certification and maintenance of certification processes.